Lidrol Bioactive Flavour Essence - Synthetic Food-Grade SARM
PRODUCT STRENGTH (CONCENTRATION)
Methyl (E)-2-((4-hydroxy-3,5-dimethoxybenzylidene)amino)benzoate 100mg/ml
Lidrol is suitable for use by both males and females.
ADMINISTRATION OF PRODUCT
Recommended dosage is 1ml (one full dropper) daily with food, administered in the morning, and mixed into 250ml juice, protein shake, or pre-workout.
- For anabolic benefits: 1ml per day, for 30 days
Cycle duration: 30 days
1 - Roell, D., Rösler, T. W., Degen, S., Matusch, R., & Baniahmad, A. (2011). Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation. Chemical biology & drug design, 77(6), 450-459.
2 - Negro-Vilar, A. (1999). Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3459-3462.
3 - Yin, D., Gao, W., Kearbey, J. D., Xu, H., Chung, K., He, Y., ... & Dalton, J. T. (2003). Pharmacodynamics of selective androgen receptor modulators. Journal of Pharmacology and Experimental Therapeutics, 304(3), 1334-1340.
4 - https://tga-search.clients.funnelback.com/s/search.html?query=&collection=tga-artg
5 - Gill, A. (2017). Standard for the uniform scheduling of medicines and poisons: The Poisons Standard 2017. Australian Government–Department of health and aging: Therapeutic Goods Administration, Canberra.
6 - Nickols, N. G., & Dervan, P. B. (2007). Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide. Proceedings of the National Academy of Sciences, 104(25), 10418-10423.
7 - Masiello, D., Cheng, S., Bubley, G. J., Lu, M. L., & Balk, S. P. (2002). Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. Journal of Biological Chemistry, 277(29), 26321-26326.
8 - Sieber, P. R., Keiller, D. L., Kahnoski, R. J., Gallo, J., & Mcfadden, S. (2004). Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer. The Journal of urology, 171(6), 2272-2276.
9 - Schellhammer, P. F. (2002). An evaluation of bicalutamide in the treatment of prostate cancer. Expert opinion on pharmacotherapy, 3(9), 1313-1328.
10 - Roell, D., Rösler, T. W., Degen, S., Matusch, R., & Baniahmad, A. (2011). Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation. Chemical biology & drug design, 77(6), 450-459.
- Product Code: Lidrol
- Availability: In Stock
- Ex Tax: $129.95